| The Conformation of the Estrogen Receptor Directs Estrogen-Induced Apoptosis in Breast Cancer: A Hypothesis. | |
| | |
MedLine Citation:
|
PMID: 21660224 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: Estrogens are classified as type I (planar) and type II (angular) based on their structures. In this study we have used triphenylethylenes (TPEs) compounds related to 4OHT to address the hypothesis that the conformation of the liganded estrogen receptor (ERα) may dictate the E2-induced apoptosis of the ER+ breast cancer cells. MATERIALS AND METHODS: ERα positive MCF7:5C cells were used to study the apoptosis induced by E2, 4OHT and TPEs. Growth and apoptosis assay were used to evaluate apoptosis and the ability to reverse the E2-induced apoptosis. ERα protein were measured by western blotting to investigate the destruction of ERα by TPEs in MCF7 cells. ChIP assay were performed to study the in-vivo recruitment of ERα and SRC3 at classical E2-responsive promoter TFF1 (PS2) by TPEs. Molecular modeling was used to predict the binding mode of the TPE to the ERα. RESULTS: TPEs were not only unable to induce efficient apoptosis in MCF7:5C cells but also reversed the E2-induced apoptosis similar to 4OHT. Furthermore, the TPEs and 4OHT did not reduce the ERα protein levels unlike E2. ChIP assay confirmed very weak recruitment of SRC3 despite modest recruitment of ERα in the presence of TPEs. Molecular modeling suggested the TPE would bind in antagonistic mode with the ERα. CONCLUSION: Our results advances the hypothesis that the TPE liganded ERα complex structurally resembles the 4OHT bound ERα and cannot efficiently recruit co-activator SRC3. As a result, the TPE complex cannot induce apoptosis of ER+ breast cancer cells although it may cause growth of the breast cancer cells. The conformation of the estrogen-ER complex differentially controls growth and apoptosis. |
| | |
Authors:
|
Philipp Maximov; Surojeet Sengupta; Joan S Lewis-Wambi; Helen R Kim; Ramona F Curpan; V Craig Jordan |
Related Documents
:
|
11805144 - Platelet-activating factor, a molecular sensor for cellular damage, activates systemic ... 9764854 - Effects of uvb on the synthesis of complement proteins by keratinocytes. 18077004 - Neuronal nicotinic alpha7 receptors modulate inflammatory cytokine production in the sk... 12162444 - Arsenic carcinogenicity: relevance of c-src activation. 18316614 - Multidrug resistance-associated protein-overexpressing teniposide-resistant human lymph... 15897804 - Interleukin 10 extends the effectiveness of standard therapy during late sepsis with se... |
Publication Detail:
|
Type: JOURNAL ARTICLE |
Journal Detail:
|
Title: Hormone molecular biology and clinical investigation Volume: 5 ISSN: 1868-1891 ISO Abbreviation: - Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-6-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101538885 Medline TA: Horm Mol Biol Clin Investig Country: - |
Other Details:
|
Languages: ENG Pagination: 27-34 Citation Subset: - |
Affiliation:
|
Fox Chase Cancer Center, Philadelphia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Grant Support | |
ID/Acronym/Agency:
|
P30 CA051008-16S9//NCI NIH HHS |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Malignancy-associated dyslipidemia.
Next Document: Statistical Fusion of Continuous Labels: Identification of Cardiac Landmarks.